Actavis PLC (NYSE:ACT)

Thursday’s trading has closed, but ACT is being traded in the after-hours session. After-Hours quote »
301.32
Delayed Data
As of 4:03pm ET
 +0.69 / +0.23%
Today’s Change
184.71
Today|||52-Week Range
317.72
+17.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$121.8B

Company Description

Actavis plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products. The company operates through the following segments: North American Brands, North American Generics and International, and Anda. Actavis was founded on October 1, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Actavis Plc
1 Grand Canal Square
Dublin Dublin 2
P:3538622617000
Investor Relations:
(862) 261-7152

Employees

Shareholders

Mutual fund holders49.24%
Other institutional46.93%
Individual stakeholders0.42%

Top Executives

Brenton L. SaundersPresident, Chief Executive Officer & Director
Robert A. StewartChief Operating Officer
Maria Teresa HiladoChief Financial Officer
Jonathon KellermanGlobal Chief Compliance Officer & Executive VP
James DareccaChief Accounting Officer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account